Cencora is excited to be joining AMCP Nexus 2026, where nearly 3,000 managed care pharmacy leaders will come together to connect, collaborate, and explore the future of pharmacy.
As a long-time partner of AMCP, we remain deeply committed to supporting the mission of helping patients access the medications they need at an affordable cost. This year's event promises meaningful opportunities for collaboration and fresh perspectives on the evolving world of managed care pharmacy.
As a long-time partner of AMCP, we remain deeply committed to supporting the mission of helping patients access the medications they need at an affordable cost. This year's event promises meaningful opportunities for collaboration and fresh perspectives on the evolving world of managed care pharmacy.
Speaker sessions and demonstrations
Education session
Is Your Organization Ready for AI? A Managed Care Playbook
Date: Tuesday, October 27, 2026
Time: 10:15am - 11:15am PT
Time: 10:15am - 11:15am PT
Spotlight session
Spotlight on 6.0: The AMCP Format for Formulary Submissions
Date: Tuesday, October 27, 2026
Time: 11:45am - 12:15pm PT
Time: 11:45am - 12:15pm PT
Lunch and Learn
Strengthen your Market Access Strategy with Intelligence from Healthcare Decision-Makers
Date: Tuesday, October 27, 2026
Time: 12:00pm – 1:00pm PT
Time: 12:00pm – 1:00pm PT
Showcase
AMCP Managed Care Pharmacy Residency & Fellowship Showcase
Date: Wednesday, October 28, 2026
Time: 5:00pm – 7:30pm PT
Time: 5:00pm – 7:30pm PT
Explore our research presented during the Expo
- Payer coverage and management of anti-obesity medications (AOMs) on commercial formularies: Results from a 2026 US national payer survey
- Payer perspectives on direct-to-patient (DTP) offerings for anti-obesity medications (AOMs): Results from a 2026 US national payer survey
- Payer formulary strategies for adalimumab and ustekinumab biosimilars in the United States: results from a 2026 survey
- The current state of biosimilar coverage and formulary management in the United States: results from a 2026 payer survey
- Addressing data gaps and early engagement preferences among healthcare decision-makers for cell and gene therapies
- An expectation for proactive pre-approval information exchange (PIE): Healthcare decision-maker preferences for PIE engagements
- Payer engagement with pre-approval and evidence resources: a real-world analysis of engagement timing and patterns
- Current trends in artificial intelligence use in managed care
- Trends in biosimilar formulary and contracting strategy from 2021 to 2026
* Available in English only.
Schedule a meeting at the conference
Our consultants cover diverse expertise-reimbursement strategy, payer insights, stakeholder engagement, field support-aiding biopharma partners in optimizing product value for market access.
Schedule a meeting with our experts to explore how our life-cycle solutions drive value and access.
Schedule a meeting with our experts to explore how our life-cycle solutions drive value and access.
FormularyDecisions® delivers unrivaled opportunities for biopharma companies to reach out to, and connect with, payers
Increase engagement
Biopharma companies who fully take advantage of the FormularyDecisions platform and all its features enjoy greater levels of engagement with the payer community, helping build a stronger level of awareness and relationships with payers.
Drive awareness
In the current landscape, it’s harder than ever for biopharma companies to get in-person meetings with payers. FormularyDecisions enables easy outreach to, and engagement with, these critical stakeholders.
Monitor competition
With unparalleled insights into how their product compares with direct competitors, biopharma companies get a full view of the landscape in the therapeutic space, and learn what they can do to stay ahead of the curve.
Leverage and understand insights
With direct real-time feedback from payers on a product, biopharma companies can get a better understanding of payer perceptions and refine their information so it resonates better with payers
Transform evidence and insights into effective market access strategies
Our commercialization strategy and market access solutions help ensure speed to market through responsive, solutions-oriented strategies that help drive efficiency in execution and resource allocation to maximize patient access to appropriate therapies.
With team across North America, Europe, and Asia-Pacific region, we blend global reach with local expertise
3,000
Consultants worldwide
30+
Global markets covered
235+
Brands represented
